Effect of epoetin beta pegol treatment on renal anemia and blood pressure control in non-dialytic CKD patients
Not Applicable
- Conditions
- non-dyalitic chronic kidney disease (CKD)
- Registration Number
- JPRN-UMIN000009449
- Lead Sponsor
- Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Allergic to erythropoiesis stimulating agents (ESA) 2. Either malignant diseases, severe infectious diseases, or significant adverse conditions complicated 3. Other inadequate occasions assessed by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood Hb level before and after epoetin beta pegol treatment and mean blood pressure as well as its fluctuation during outpatient clinic.
- Secondary Outcome Measures
Name Time Method Correlation between blood pressure fluctuation and incidence of cardiovascular events before and after epoetin beta pegol treatment.